Literature DB >> 28711638

The alteration of temoporfin distribution in multicellular tumor spheroids by β-cyclodextrins.

Ilya Yakavets1, Igor Yankovsky2, Marie Millard3, Laureline Lamy4, Henri-Pierre Lassalle3, Arno Wiehe5, Vladimir Zorin6, Lina Bezdetnaya7.   

Abstract

To be effective anticancer drugs must penetrate tissue efficiently, reaching all target population of cancer cells in a concentration sufficient to exert a therapeutic effect. This study aimed to investigate the ability of methyl-β-cyclodextrin (Me-β-CD) and 2-hydroxypropyl-β-cyclodextrin (Hp-β-CD) to alter the penetration and diffusion of temoporfin (mTHPC) in HT29 multicellular tumor spheroids. mTHPC had а nonhomogenous distribution only on the periphery of spheroids. The presence of β-CDs significantly altered the distribution of mTHPC consisting in the increase of both the depth of photosensitizer penetration and accumulation in HT29 spheroids. We suggest that this improvement is related to the nanoshuttle mechanism of β-CD action, when β-CDs facilitate mTHPC transportation to the cells in the inner layers of spheroids. As a result of mTHPC distribution improvement, β-CDs enhance mTHPC photosensitizing activity towards HT29 multicellular tumor spheroids. The observed effects strongly depend on the type of β-CD. Thus, varying the type of β-CD we can finely tune the possibility of using mTHPC for diagnostic (delimitation of tumor margins) or therapeutic purposes.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2-Hydroxypropyl-β-cyclodextrin (PubChem CID: 44134771); Cyclodextrins; Inclusion complexes; Methyl-β-cyclodextrin (PubChem CID: 51051622); Penetration; Photodynamic therapy; Spheroid; mTHPC; meta-Tetrakis(3-hydroxyphenyl)chlorin (PubChem CID: 60751)

Mesh:

Substances:

Year:  2017        PMID: 28711638     DOI: 10.1016/j.ijpharm.2017.07.037

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

Review 1.  Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment.

Authors:  Amina Ben Mihoub; Ludivine Larue; Albert Moussaron; Zahraa Youssef; Ludovic Colombeau; Francis Baros; Céline Frochot; Régis Vanderesse; Samir Acherar
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

Review 2.  Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening.

Authors:  Marie Millard; Ilya Yakavets; Vladimir Zorin; Aigul Kulmukhamedova; Sophie Marchal; Lina Bezdetnaya
Journal:  Int J Nanomedicine       Date:  2017-10-31

3.  Stroma-Rich Co-Culture Multicellular Tumor Spheroids as a Tool for Photoactive Drugs Screening.

Authors:  Ilya Yakavets; Samuel Jenard; Aurelie Francois; Yulia Maklygina; Victor Loschenov; Henri-Pierre Lassalle; Gilles Dolivet; Lina Bezdetnaya
Journal:  J Clin Med       Date:  2019-10-15       Impact factor: 4.241

Review 4.  Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research.

Authors:  Bárbara Pinto; Ana C Henriques; Patrícia M A Silva; Hassan Bousbaa
Journal:  Pharmaceutics       Date:  2020-12-06       Impact factor: 6.321

5.  Porous Polymeric Microspheres With Controllable Pore Diameters for Tissue Engineered Lung Tumor Model Development.

Authors:  Dinesh Dhamecha; Duong Le; Rachel Movsas; Andrea Gonsalves; Jyothi U Menon
Journal:  Front Bioeng Biotechnol       Date:  2020-07-10

6.  Temoporfin-in-Cyclodextrin-in-Liposome-A New Approach for Anticancer Drug Delivery: The Optimization of Composition.

Authors:  Ilya Yakavets; Henri-Pierre Lassalle; Dietrich Scheglmann; Arno Wiehe; Vladimir Zorin; Lina Bezdetnaya
Journal:  Nanomaterials (Basel)       Date:  2018-10-18       Impact factor: 5.076

Review 7.  Recent Progress in Metal-Based Nanoparticles Mediated Photodynamic Therapy.

Authors:  Jingyao Sun; Semen Kormakov; Ying Liu; Yao Huang; Daming Wu; Zhaogang Yang
Journal:  Molecules       Date:  2018-07-12       Impact factor: 4.411

8.  Matryoshka-Type Liposomes Offer the Improved Delivery of Temoporfin to Tumor Spheroids.

Authors:  Ilya Yakavets; Marie Millard; Laureline Lamy; Aurelie Francois; Dietrich Scheglmann; Arno Wiehe; Henri-Pierre Lassalle; Vladimir Zorin; Lina Bezdetnaya
Journal:  Cancers (Basel)       Date:  2019-09-13       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.